These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

224 related items for PubMed ID: 20579105

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Yeast as a model for studying neurodegeneration].
    Wawrzycka D.
    Postepy Hig Med Dosw (Online); 2011 Jun 02; 65():328-37. PubMed ID: 21677357
    [Abstract] [Full Text] [Related]

  • 5. Harnessing the power of yeast to unravel the molecular basis of neurodegeneration.
    Tenreiro S, Munder MC, Alberti S, Outeiro TF.
    J Neurochem; 2013 Nov 02; 127(4):438-52. PubMed ID: 23600759
    [Abstract] [Full Text] [Related]

  • 6. Nervous yeast: modeling neurotoxic cell death.
    Braun RJ, Büttner S, Ring J, Kroemer G, Madeo F.
    Trends Biochem Sci; 2010 Mar 02; 35(3):135-44. PubMed ID: 19926288
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Yeast unfolds the road map toward alpha-synuclein-induced cell death.
    Franssens V, Boelen E, Anandhakumar J, Vanhelmont T, Büttner S, Winderickx J.
    Cell Death Differ; 2010 May 02; 17(5):746-53. PubMed ID: 20019751
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. From the bakery to the brain business: developing inducible yeast models of human neurodegenerative disorders.
    Ocampo A, Barrientos A.
    Biotechniques; 2008 Oct 02; 45(4):vii-xiv. PubMed ID: 18855765
    [Abstract] [Full Text] [Related]

  • 11. Screening for genetic modifiers of amyloid toxicity in yeast.
    Giorgini F, Muchowski PJ.
    Methods Enzymol; 2006 Oct 02; 412():201-22. PubMed ID: 17046660
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Mechanisms of Disease: astrocytes in neurodegenerative disease.
    Maragakis NJ, Rothstein JD.
    Nat Clin Pract Neurol; 2006 Dec 02; 2(12):679-89. PubMed ID: 17117171
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Regulators of adult neurogenesis in the healthy and diseased brain.
    Grote HE, Hannan AJ.
    Clin Exp Pharmacol Physiol; 2007 Dec 02; 34(5-6):533-45. PubMed ID: 17439429
    [Abstract] [Full Text] [Related]

  • 18. Yeast models of Parkinson's disease-associated molecular pathologies.
    Tenreiro S, Franssens V, Winderickx J, Outeiro TF.
    Curr Opin Genet Dev; 2017 Jun 02; 44():74-83. PubMed ID: 28232272
    [Abstract] [Full Text] [Related]

  • 19. Mechanisms of neurodegeneration in idiopathic Parkinson's disease.
    Schulz JB.
    Parkinsonism Relat Disord; 2007 Jun 02; 13 Suppl 3():S306-8. PubMed ID: 18267255
    [Abstract] [Full Text] [Related]

  • 20. Yeast at the Forefront of Research on Ageing and Age-Related Diseases.
    Sampaio-Marques B, Burhans WC, Ludovico P.
    Prog Mol Subcell Biol; 2019 Jun 02; 58():217-242. PubMed ID: 30911895
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.